Emerald Advisors LLC Has $340,000 Stock Holdings in UnitedHealth Group Incorporated $UNH

Emerald Advisors LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.4% during the second quarter, HoldingsChannel reports. The firm owned 1,089 shares of the healthcare conglomerate’s stock after acquiring an additional 177 shares during the quarter. Emerald Advisors LLC’s holdings in UnitedHealth Group were worth $340,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Brighton Jones LLC lifted its stake in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Baker Tilly Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 5.4% in the 1st quarter. Baker Tilly Wealth Management LLC now owns 1,276 shares of the healthcare conglomerate’s stock valued at $668,000 after acquiring an additional 65 shares during the last quarter. Fiduciary Alliance LLC lifted its stake in shares of UnitedHealth Group by 2.8% in the 1st quarter. Fiduciary Alliance LLC now owns 10,172 shares of the healthcare conglomerate’s stock valued at $5,328,000 after acquiring an additional 279 shares during the last quarter. Finally, NBC Securities Inc. lifted its stake in shares of UnitedHealth Group by 71,127.3% in the 1st quarter. NBC Securities Inc. now owns 7,835 shares of the healthcare conglomerate’s stock valued at $4,103,000 after acquiring an additional 7,824 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $344.61 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a 50-day moving average price of $302.45 and a two-hundred day moving average price of $357.73. The company has a market cap of $312.10 billion, a P/E ratio of 14.93, a PEG ratio of 2.24 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on UNH shares. Morgan Stanley raised their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Sanford C. Bernstein raised their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, JPMorgan Chase & Co. lowered their target price on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.